YA

Yogesh Agarwal

Active Director Designated Partner DIN 06869200
DIN 06869200 First appointment Jun 2014 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Yogesh Agarwal

Data last updated:

Yogesh Agarwal is a Designated Partner at Yal Biotechnologies Limited Liability Partnership (since 2014). The company operates in Business Services.

DIN 06869200
Primary Designation Designated Partner
Industry Business Services
First Appointment 23 Jun 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Jun 20142014Active

Board colleagues of Yogesh Agarwal

NameDINCompanyDesignation
Lokesh Kumar06869236Yal Biotechnologies Limited Liability PartnershipDesignated Partner

Directorship timeline

Open interactive timeline →
Yal Biotechnologies Limited Liability Partnership
Premium access

Shareholding and investment profile for Yogesh Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Agarwal

Yogesh Agarwal currently holds 1 directorship: Yal Biotechnologies Limited Liability Partnership (Designated Partner, since 23 Jun 2014).

Yogesh Agarwal was first appointed on 23 Jun 2014 as Designated Partner at Yal Biotechnologies Limited Liability Partnership.

The current boards of Yogesh Agarwal's companies include Lokesh Kumar (Yal Biotechnologies Limited Liability Partnership).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available